2Department of Theriogenology, Faculty of Veterinary Medicine, Assiut University, Assiut, Egypt
Date of Receipt: 16-11-2018; Date of Revision: 18-11-2018; Date of Acceptance: 21-11-2018
Progesterone (P4) and vitamin E (Vitamin E) are important in early stage of pregnancy especially in young does. The goal was to investigate effect of injection of P4, Vitamin E and their integration on pregnancy enhancement, embryo dimensions and P4 concentration in young does. 24 animals were divided into 4 equal groups: control group, P4 group (each doe was injected i.m with single dose of 1.0 mg long-acting P4 two days post-mating), Vitamin E group (each doe was injected i.m with 20 IU Vitamin E/kg BW every 3 days from mating to mid-pregnancy and P4+Vitamin E group. All does were ultrasono-graphically examined at days 7,10,12,14,16,18,20 and 22 of pregnancy. Results revealed that P4 and P4+Vitamin E treatment facilitated establishment of pregnancy on day 7 of pregnancy more than the control and Vitamin E alone. Amniotic vesicles diameters on day 12 and fetal length on days 14 and 16 were greater (P<0.05) in P4 and P4+Vitamin E groups. On days 18-22, fetus length was significantly larger in P4 group. P4 concentrations at first week and mid-pregnancy were significantly greater in P4 group followed by P4+Vitamin E.
Conclusion: P4 and P4+Vitamin E enhanced the early stage of pregnancy during the first parity of rabbit does.
Progesterone, Vitamin E, Pregnancy, Embryo, Progesterone profile, Young rabbit
Rabbit are widely used for human consumption and in reproductive medical experiments. After fertilization, P4 produced from the corpus luteum is known to prepare the uterine lining for zygote implantation and to prevent the uterine contractions for maintenance of pregnancy. Embryo survival is dependent on the uterine environment and composition of its fluid during the luteal phase prior to implantation. Thus, a relationship between P4 concentration released in the early luteal phase and embryo loss  has a physiological basis in uterine growth and suppression of myometrial contractility . Also, a delay in P4 secretion during the early post-ovulatory luteal phase had a negative impact on embryo survival . Similarly, daily injections of 25 mg P4 from 36 h post-mating in ewes increased blastocyst diameter by 220% on day 9 and advanced the time of elongation of blastocysts to a filamentous conceptus [4,5]. However, young does that gestate at first time are usually poor in P4 production due to inadequate CL development.
Antioxidant vitamins, alone or combined with other supplements, decrease embryonic mortality and improve birth outcomes . Previous studies [7,8] indicated that oxidative damage on DNA, protein, and lipids during pregnancy may be associated with reduced birth weight and increased risks of preterm delivery and preeclampsia. Hence, filling reproductive tissues of pregnant dames by potential antioxidants can protect the maternal-fetal unit and increase the intrauterine growth and infant weight at birth. Vitamin E is a lipid soluble, chain-breaking antioxidant that is dietary in origin. Vitamin E has potential consequence on the outcome of pregnancy via prostacyclin , where vitamin E enhanced the release of prostacyclin, it metabolite of arachadonic acid, which inhibits platelet aggregation, retarded uterine contractility, and increased vasodilation . Both α- and γ-tocopherols could be involved in the fetal growth by increasing blood flow to the fetus. Therefore, the objective of this study is to investigate the effect of P4 and Vitamin E injections and their integration on pregnancy enhancement, embryo development and peripheral P4 concentrations in young rabbit does.
The experiment was carried out in the Animal House, Faculty of Medicine, Assiut University, Assiut, Egypt in early spring.
A total of 24 virgin female WNZ rabbit does (6 months of age) with a mean body weight of 2.35 ± 0.49 kg were divided randomly into four groups of six does per each. Rabbits were vaccinated to protect animals from bacterial septicemia and viral hemorrhagic diseases. Does in the first group were injected i.m. with saline solution 2 days after natural mating and considered as the control for the treated groups. Does in the second group were injected i.m. with a single dose of 1.0 mg long-acting progesterone (P4, hydroxyl-progesterone caprote, Cidolut Depot, CID, Egypt) 2 days after natural mating. Does in the third group were injected i.m. with 20 IU Vitamin E (Pharco Pharmaceutical, Alex, Eg.) per kg body weight every 3 days after natural mating until mid-pregnancy (day 15). Does in the fourth group were injected i.m with both P4 and Vitamin E.
All does were fed a diet containing 18.25% crude protein, 2.29% crude fat (2700 kcal/kg ration metabolizable energy (ME) according to  and 13.4% crude fiber. The amount of Vitamin E in this diet was 30-50 mg/kg diet. Ingredient constituents of the diet were yellow corn, wheat bran, soybean meal (44%), dicalcium phosphate, limestone, sodium chloride, methionine, premix, molasses and alfalfa hay. Green roughage and water were supplied ad libitum throughout the experiment. Each doe was fed ad libitum on this commercial diet throughout the experiment.
Rabbits were reared in individual cages (50 × 60 cm × 35 cm) of galvanized wire net, equipped with an automatic drinker and a manual feeder. These cages were put in rooms with comfortable environmental conditions, the temperature and humidity inside the room (31 m × 8 m × 3 m) were 19°C-22°C and 75%-80%, respectively. Temperature and humidity were maintained using an air conditioner-heater system and forced ventilation to remove gases such as carbon dioxide. Does were housed under 14 h light: 10 h dark throughout the experiment.
All does were mated naturally by WNZ fertile bucks selected on basis of vigor, physical conformation and semen quality. The rabbit doe was brought to the buck’s hutch, mated during a 10 min interval and re-mated within 4 h after the initial mating. This short interval between mating may increase the probability of conception as remating 36 h after the initial mating may cause undesirable alteration of estrogen and P4 in this induced ovulatory and lead to abortion or miscarriage.
Blood samples were withdrawn from all does by using 25-gauge needle attached with 3 cc syringes during premating, 7 days post-mating and mid-pregnancy (total of 72 samples). Approximately 3 ml blood was collected from each doe via the central ear vein. Before collection, one drop of Xylol was spread on the ear by using small clean cotton for increasing the blood flow in the ear veins . Blood samples were allowed to clot at 4°C overnight in the refrigerator and centrifuged at 2000 × g for 20 min. After centrifugation, sera were collected in 4 ml eppendorf tubes and stored at -20°C until P4 assay.
Progesterone (P4) Assay
P4 was assayed by competitive immunoluminometric assay (Maglumi Prog, Shenzhen New Industries Biomedical Engineering Co. Ltd, London, UK). This method was based on the principle of competitive binding with an assay range of 0-80 ng/ml.
Ultrasonography was used in this experiment for pregnancy diagnosis and determination of embryo development on days 7, 10, 12, 14, 16, 18, 20 and 22 after mating. After shaving hair from the belly, the uterus of each doe was examined trans-abdominally by Doppler ultrasonographic technique (ESAOTE/Pie Medical My Lab 30 vet deviceviadi Caciolle,15-50/27, Frienze, Italy) . This method was equipped on 6 MH2 and the probe was positioned externally against the abdominal wall while the doe was restrained in a dorsal recumbent position. Diagnosis of pregnancy was confirmed by palpation on day 12 after mating according to .
Data of were analyzed statistically (one and two way analysis of variance) using the GLM procedure of SPSS software . 20 Differences between LSM were analyzed by using . Data in percentage values were transformed with the arcsine square root procedure to normalize the variance before analyzing the data.
Embryo and Fetus Development
On day 7 after mating, there were no significant differences in uterine diameters of non-pregnant treated groups and controls one. The non-gravid uterus contained hypoechogenic (dark grey) linear structure with diameter 0.34 ± 0.09 cm without any contents in the lumen (Figure 1), where the percentages were 11%, 50% and 25% in P4, Vitamin E and P4+Vitamin E) Compared with the control one (45%). While In pregnant does, the gravid uterus of pregnancy contained an echogenic (black) amniotic vesicle in the uterine lumen with hyperechogenic (white) eccentric masses which represents the fetuses (Figure 2). Pregnancy rates were 89%, 50% and 75% in P4, Vitamin E and P4+Vitamin E compared with 55% in the control. There were significant differences between the P4 group and control group (P<0.05). The amniotic vesicle diameter was larger in P4 group of pregnant does (0.89 ± 0.34 cm) compared with the control (0.53 ± 0.11 cm). Otherwise, amniotic vesicle diameter was not affected by treatment of Vitamin E alone (P>0.05). Doppler analyses did not detect significant differences in the blood supply perfusion due to treatments and the controls.
On day 10, the gravid uterus contained anechogenic (black) amniotic vesicles in the lumen with larger hyperechogenic mass than observed on day 7 of pregnancy. The number of fetuses could be counted (Figure 3) (P<0.05) in P4 and control groups. Amniotic vesicles diameters were again larger in P4 group (1.19 ± 0.11 cm) compared with the control (0.71 ± 0.09 cm; P<0.05). Treatment with vitamin E again did not affect amniotic vesicle diameter.
On day 12, the diameter of the amniotic vesicle was larger than that observed on day 10 after mating. Moreover, blood supply of fetus and uterus increased in this period (Figure 4). Also, diameters of amniotic vesicles contained fetuses were significantly (P<0.05) larger in P4 and P4+Vitamin E groups than Vitamin E group and control one (2.31 ± 0.43 cm vs. 1.63 ± 0.28 cm, respectively) where, Vitamin E group was similar to the control one.
On day 14, the fetus was more visible in the uterus with heart beats detectable in all fetuses, where, crown rump length (fetus length) was 1.89 ± 0.36 cm, 1.78 ± 0.22 cm, and 1.30 ± 0.17 cm in P4, Vitamin E+P4 and Vitamin E groups vs. 1.23 ± 0.39 cm in the control. This fetal size was significantly (P<0.05) larger in P4 and P4+Vitamin E groups than in the Vitamin E group and the control one. Blood supply was not significantly different among the studied groups. The number of fetuses could be counted in that period.
On day 16, fetus length continued to be larger (P<0.05) in both P4 and Vitamin E+P4 groups (1.94 ± 0.25 cm and 1.86 ± 0.36 cm) compared with the Vitamin E group and the control (1.53 ± 0.11 cm and 1.44 ± 0.27 cm. Number of fetuses could be counted during that period, but there were no significant differences in the blood supply among the groups.
On day 18, fetuses occupied all spaces of uterus; hence, therefore, number of fetuses could not be counted easily. Fetus length was significantly longer in P4 group (2.54 ± 0.33 cm) than in other groups with averaged lengths of 2.01 ± 0.16 cm in Vitamin E+P4, 1.94 ± 0.23 cm in Vitamin E and 1.89 ± 0.14 cm in the control (Figure 5). Blood supply was not affected by treatments.
On day 20, fetuses could not be counted, but fetus length increased significantly in P4 group (2.83 ± 0.21 cm) compared with the other groups 2.22 ± 0.31 cm (Vitamin E+P4), 2.08 ± 0.27 cm (Vitamin E) and 1.99 ± 0.14 cm (control) (Figure 6). Fetal parts such as trunk and head could be distinguished (Figure 7). While, blood supply was not affected by treatments.
Similarly, on days 20 and 22, fetuses occupied the whole uterine lumen with relatively small amounts of fetal fluid surrounding the fetuses. Fetus length was larger in P4 group (3.64± 0.53 cm) compared with the other groups 3.03 ± 0.49 cm (Vitamin E+P4), 3.07 ± 0.36 cm (Vitamin E) and 2.98 ± 0.33 cm controls (Figure 8). Fetal parts such as vertebral column and ribs could be distinguished in Figure 7, while blood supply was not influenced by treatments.
P4 concentration was significantly higher at one week of pregnancy in P4 group (4.97 ± 1.27 ng/ml blood serum) than the other treatments. P4 concentration continued to rise to reach 12.45 ± 2.79 ng/ml in mid-gestation of does treated by P4 compared with control and Vitamin E groups. Moreover, P4 concentration did not differ between the does treated with Vitamin E and the controls Figure 8. While, P4 concentration in combined group was similar to that in P4 group.
Synchrony between mammalian embryo implantation and uterine development are essential for subsequent development of embryos. Rabbit embryos can tolerate up to two days of asynchrony [16,17]. Administration of P4 can advance the secretion of characteristic uterine proteins in the rabbit . Our results revealed that P4 alone or in combination with Vitamin E facilitated establishment of pregnancy and maintained embryonic survival during early stage of pregnancy (first week) these results are coincident with findings obtained by [3,19] who indicated that P4 concentration might be related to the embryo survival and low P4 concentrations during the early post-ovulatory luteal phase or a delay in its normal rise in that period were associated with reducing embryo survival. Further, lack of corpora lutea reduced embryo survival in rabbits . This means that use of P4 in the current study could protect embryos from mortality presumably either by reducing myometrial contraction or by maintaining maternal extracellular fluid volume during pregnancy, where  indicated that rate of oviduct fluid secretion was regulated by ovarian hormones and uterine milieu during early pregnancy contained at least a 3-fold increase in nutrients compared with non-pregnant animals . Antioxidant vitamins alone or combined with other supplements, decreased embryonic mortality and improved birth outcomes [6,22]. There are contradictory results in regard to the role if Vitamin E on fetal growth [23,24]. However, the increased amniotic vesicle diameter observed in the present study may due to effect of P4 dose; this is similar to the increased growth of day 9-12 embryos stimulated by P4 supplementation in sheep . Also, P4 administration led to increased fetal length on days 14, 16 and 22, this may be attributed to effects of P4-induced changes in gene expression of uterine tissues [4,25,26] and changes in composition of histotroph surrounding developing embryo. In cows, administration of P4 at days 1-4 of pregnancy enhanced fetal development (measured on day 14) compared with control [27,28]. Similarly, ewes received P4 on day 1-3, 3-6 or 1-6 of pregnancy had higher plasma P4 than the control and fetal growth was greatest when the treatment started on day 1 of pregnancy . Previous study  reported that embryo survival was associated with large variations in P4 secretion during first few days after ovulation and the high P4 concentrations were related to the embryo survival. In the present study, P4 concentrations in does treated with P4 and P4+Vitamin E was higher than that treated with Vitamin E only and the controls. Previous study [31,32] reported that the increased P4 concentrations on days 12 and 24 of pregnant rabbits may be attributed to the positive impact of Vitamin E and Se intake on P4 concentration. Further, P4 concentrations increased in the second half of pregnancy on days 12 and 13 with a peak on days 14-17 .
P4 alone or combined with Vitamin E maintained embryo survival and pregnancy in young does. Vitamin E alone did not have a significant effect. Hence P4 and P4+Vitamin E may be applied successfully to enhance pregnancy in rabbit does and in utero development of offspring.
Authors would like to thank Assiut University for funding this research article.